PD46-12 PRECLINICAL STUDIES USING CISPLATIN/CARBOPLATIN TO RESTORE THE ENZALUTAMIDE SENSITIVITY VIA DEGRADING THE ANDROGEN RECEPTOR SPLICING VARIANT 7 (ARV7) TO FURTHER SUPPRESS ENZALUTAMIDE RESISTANT PROSTATE CANCER
- Resource Type
- Source
- Journal of Urology. 207
- Subject
Urology - Language
- ISSN
- 1527-3792
0022-5347